A comprehensive review on Covid-19 Omicron (B.1.1.529) variant

被引:25
|
作者
Manjunath, R. [1 ]
Gaonkar, Santosh L. [1 ]
Saleh, Ebraheem Abdu Musad [2 ]
Husain, Kakul [2 ]
机构
[1] Manipal Acad Higher Educ, Manipal Inst Technol, Dept Chem, Manipal 576104, Karnataka, India
[2] Prince Sattam Bin Abdulaziz Univ, Coll Arts & Sci, Dept Chem, Wadi Al Dawasir 11991, Saudi Arabia
关键词
Omicron (B; 1; 529); Receptor binding domain (RBD); Spike protein; Monoclonal antibodies(mAb); Titers; Phylogeny; Lineage; Clade; SCIENTISTS;
D O I
10.1016/j.sjbs.2022.103372
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
The world has been combating different variants of SARS-COV-19 since its first outbreak in Wuhan city. SARS-COV-19 is caused by the coronavirus. The corona virus mutates and becomes more transmissible than earlier variants as the day passes. Till 24 November 2021, SARS-COV-19 has four variants Alpha, Beta, Gamma, and Delta, respectively. Among them, the delta variant caused severe havoc across the world. South Africa registered a new variant with the World Health Organization (WHO) on 24 November 2021, which is much more transmissible than previous variants. The WHO classified it as a variant of concern (VOC) on 26 November 2021 and called it the Greek letter Omicron (B.1.1.529), the fifteenth letter in the alphabet. Here a serious attempt was made to comprehend the omicron variant's origin, nomenclature, characteristics, mutations, the difference between delta and omicron variant, epi-demiology, transmission, clinical features, impact on immunity, immune evasion, vaccines efficacy, etc.(c) 2022 Published by Elsevier B.V. on behalf of King Saud University. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
引用
收藏
页数:18
相关论文
共 50 条
  • [1] Covid-19 Vaccine Effectiveness against the Omicron (B.1.1.529) Variant
    Andrews, N.
    Stowe, J.
    Kirsebom, F.
    Toffa, S.
    Rickeard, T.
    Gallagher, E.
    Gower, C.
    Kall, M.
    Groves, N.
    O'connell, A-M
    Simons, D.
    Blomquist, P. B.
    Zaidi, A.
    Nash, S.
    Aziz, N. Iwani Binti Abdul
    Thelwall, S.
    Dabrera, G.
    Myers, R.
    Amirthalingam, G.
    Gharbia, S.
    Barrett, J. C.
    Elson, R.
    Ladhani, S. N.
    Ferguson, N.
    Zambon, M.
    Campbell, C. N. J.
    Brown, K.
    Hopkins, S.
    Chand, M.
    Ramsay, M.
    Bernal, J. Lopez
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2022, 386 (16): : 1532 - 1546
  • [2] DRUG DESIGN OF MEDICINAL PLANTS AS A TREATMENT OF OMICRON VARIANT (COVID-19 VARIANT B.1.1.529)
    Mollaamin, Fatemeh
    Shahriari, Sara
    Monajjemi, Majid
    [J]. JOURNAL OF THE CHILEAN CHEMICAL SOCIETY, 2022, 67 (03): : 5562 - 5570
  • [3] SARS-CoV-2 Omicron (B.1.1.529) Variant: A Challenge with COVID-19
    Afshar, Zeinab Mohseni
    Pirzaman, Ali Tavakoli
    Karim, Bardia
    Anaraki, Shiva Rahimipour
    Hosseinzadeh, Rezvan
    Pireivatlou, Elaheh Sanjari
    Babazadeh, Arefeh
    Hosseinzadeh, Dariush
    Miri, Seyed Rouhollah
    Sio, Terence T.
    Sullman, Mark J. M.
    Barary, Mohammad
    Ebrahimpour, Soheil
    [J]. DIAGNOSTICS, 2023, 13 (03)
  • [4] COVID-19 vaccination and SARS-CoV-2 Omicron (B.1.1.529) variant: a at the end of the tunnel?
    Mattiuzzi, Camilla
    Henry, Brandon M.
    Lippi, Giuseppe
    [J]. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2022, 118 : 167 - 168
  • [5] Assessing the COVID-19 vaccination program during the Omicron variant (B.1.1.529) epidemic in early 2022, Tokyo
    Kayano, Taishi
    Nishiura, Hiroshi
    [J]. BMC INFECTIOUS DISEASES, 2023, 23 (01)
  • [6] Assessing the COVID-19 vaccination program during the Omicron variant (B.1.1.529) epidemic in early 2022, Tokyo
    Taishi Kayano
    Hiroshi Nishiura
    [J]. BMC Infectious Diseases, 23
  • [7] Neutralizing potency of COVID-19 vaccines against the SARS-CoV-2 Omicron (B.1.1.529) variant
    Lippi, Giuseppe
    Mattiuzzi, Camilla
    Henry, Brandon M.
    [J]. JOURNAL OF MEDICAL VIROLOGY, 2022, 94 (05) : 1799 - 1802
  • [8] Omicron (B.1.1.529) variant: Development, dissemination, and dominance
    Rahmani, Shayan
    Rezaei, Nima
    [J]. JOURNAL OF MEDICAL VIROLOGY, 2022, 94 (05) : 1787 - 1788
  • [9] Omicron (B.1.1.529) - variant of concern - molecular profile and epidemiology: a mini review
    Kannan, S.
    Ali, P. Shaik Syed
    Sheeza, A.
    [J]. EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2021, 25 (24) : 8019 - 8022
  • [10] The SARS-CoV-2 Omicron (B.1.1.529) variant and the re-emergence of COVID-19 in Europe: An alarm for Bangladesh
    Islam, Md. Rabiul
    [J]. HEALTH SCIENCE REPORTS, 2022, 5 (02)